Skip to main content
Coburn Hobar, MD, Rheumatology, Tampa, FL

CoburnEHobarMD

Rheumatology Tampa, FL

Lupus & Related

Senior Clinical Trial Physician

Dr. Hobar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hobar's full profile

Already have an account?

Education & Training

  • University of Tennessee
    University of TennesseeFellowship, Rheumatology, 2000 - 2002
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1997 - 2000
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 1997

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2002 - 2020

Publications & Presentations

PubMed

Abstracts/Posters

  • EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYK2 INHIBITOR, IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: A PHASE 2, RANDOMIZED, DOU...
    E Morand, M Pike, JT Merrell, R van Vollenhoven, VP Werth, C Hobar, N Delev, V Shah, B Sharkey, T Wegman, I Catlett, S Bannerjee, S Singhal, Annals of the Rheumatic Diseases, EULAR 2022, 6/4/2022
  • Oral selective tyrosine kinase 2 (TYK2) inhibition with BMS-986165 in patients with systemic lupus erythematosus: a phase 2, randomized, double-blind, placebo-controll...
    Singhal S, Shah V, Crater C, Hobar C, Nguyen H, Throup J, Banerjee S, Merrill JT, Lupus Science & Medicine 2019